NEA Management Company as of June 30, 2016
Portfolio Holdings for NEA Management Company
NEA Management Company holds 39 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tesaro | 44.8 | $864M | 10M | 84.05 | |
| Groupon | 5.6 | $108M | 33M | 3.25 | |
| Senseonics Hldgs (SENS) | 5.4 | $103M | 26M | 3.93 | |
| Ardelyx (ARDX) | 5.3 | $103M | 12M | 8.73 | |
| Dermira | 5.3 | $103M | 3.5M | 29.25 | |
| Adaptimmune Therapeutics (ADAP) | 4.2 | $81M | 9.9M | 8.15 | |
| Epizyme | 3.3 | $64M | 6.3M | 10.24 | |
| Glycomimetics (GLYC) | 3.2 | $62M | 8.6M | 7.27 | |
| Nevro (NVRO) | 2.5 | $49M | 660k | 73.76 | |
| Loxo Oncology | 2.2 | $42M | 1.8M | 23.18 | |
| Care | 2.0 | $38M | 3.3M | 11.68 | |
| Proteostasis Therapeutics In | 1.9 | $38M | 3.1M | 12.13 | |
| Lexicon Pharmaceuticals (LXRX) | 1.8 | $34M | 2.4M | 14.35 | |
| Endologix | 1.6 | $31M | 2.5M | 12.46 | |
| Aerohive Networks | 1.6 | $31M | 4.7M | 6.62 | |
| Trevena | 1.2 | $24M | 3.8M | 6.30 | |
| Achaogen | 0.9 | $18M | 4.7M | 3.79 | |
| Exelixis (EXEL) | 0.9 | $17M | 2.2M | 7.81 | |
| Clovis Oncology | 0.8 | $16M | 1.1M | 13.72 | |
| Mirna Therapeutics | 0.7 | $13M | 3.0M | 4.26 | |
| AVEO Pharmaceuticals | 0.5 | $9.9M | 10M | 0.96 | |
| Cascadian Therapeutics | 0.5 | $10M | 11M | 0.94 | |
| Strongbridge Bioph shs usd | 0.4 | $8.5M | 2.1M | 3.98 | |
| Tracon Pharmaceuticals | 0.4 | $8.3M | 1.9M | 4.38 | |
| Rigel Pharmaceuticals (RIGL) | 0.4 | $7.2M | 3.2M | 2.23 | |
| Aurinia Pharmaceuticals (AUPH) | 0.4 | $7.1M | 2.5M | 2.77 | |
| Akari Therapeutics | 0.3 | $6.1M | 452k | 13.49 | |
| Zhone Technologies | 0.3 | $5.7M | 4.8M | 1.19 | |
| ArQule | 0.2 | $4.8M | 2.5M | 1.90 | |
| Sunesis Pharmaceuticals | 0.2 | $4.3M | 7.8M | 0.55 | |
| Arca Biopharma | 0.2 | $4.2M | 1.5M | 2.90 | |
| Champions Oncology (CSBR) | 0.2 | $3.4M | 1.6M | 2.15 | |
| Zosano Pharma | 0.1 | $2.7M | 2.2M | 1.27 | |
| Roka Bioscience | 0.1 | $1.8M | 3.2M | 0.57 | |
| Orexigen Therapeutics | 0.1 | $1.6M | 371k | 4.30 | |
| Cerecor | 0.1 | $1.3M | 595k | 2.20 | |
| Agile Therapeutics | 0.1 | $1.0M | 134k | 7.61 | |
| Paratek Pharmaceuticals | 0.1 | $921k | 66k | 13.90 | |
| Catalyst Biosciences | 0.1 | $992k | 652k | 1.52 |
